Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

No treatment fully prevents hair loss from chemotherapy yet.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.